Sumant Ramachandra - Oct 31, 2024 Form 3 Insider Report for Lyell Immunopharma, Inc. (LYEL)

Role
Director
Signature
/s/ Matthew Lang, as Attorney-in-Fact
Stock symbol
LYEL
Transactions as of
Oct 31, 2024
Transactions value $
$0
Form type
3
Date filed
11/1/2024, 04:54 PM

No securities are beneficially owned.